Poor Economic Data Weighs Against Biotech Mega-Deal - Presented by: The Aol. On Network

Markets closed mixed Tuesday as poor manufacturing data and housing sentiment was weighed against a $25 billion deal in the biotech sector. Treasury yield moves suggest poor weather is not entirely to blame for lackluster economic data. Forest Laboratories jumped 29 percent after Actavis agreed to buy the maker of the Alzheimer's drug Namenda.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
F $ 15.11 1.22 ▼ 7.47%
BAC $ 17.01 0.02 ▼ 0.12%
TIBX $ 23.65 4.14 ▲ 21.22%
PBR $ 14.70 1.76 ▼ 10.69%
JNS $ 14.70 1.19 ▼ 7.49%
AAPL $ 100.11 0.64 ▼ 0.64%
RAD $ 4.95 0.27 ▼ 5.17%
ZNGA $ 2.79 0.04 ▼ 1.41%

As of 9/29/2014, 04:15 PM
More Most Active